| COVID-19 Vaccine |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Cancer |
0 |
0.99 |
| COVID-19 |
0 |
0.6 |
| Genomic Medicine |
0 |
0.49 |
| Immunoglobulin G (IgG) |
0 |
0.31 |
| Immunization |
0 |
0.95 |
| Vaccines |
0 |
0.26 |
| Chemotherapy |
0 |
0.85 |
| Immunotherapy |
0 |
0.8 |
| Transplantation |
0 |
0.2 |
| Organ Transplantation |
0 |
0.19 |
| Combination Chemotherapy |
0 |
0.17 |
| Bone Marrow Transplant |
0 |
0.16 |
| Stem Cell Research and Therapy |
0 |
0.16 |
| Tumor |
0 |
0.12 |
| Bone Marrow |
0 |
0.06 |
| Autoimmune Disease |
0 |
0.04 |
| Biomarker |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Bone |
0 |
0.04 |
| Breast |
0 |
0.04 |
| Epigenetics |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Hematology |
0 |
0.04 |
| Hemodialysis |
0 |
0.04 |
| Immunocompromise |
0 |
0.04 |
| Immunosuppressive Therapy |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.04 |
| Salary and Compensation |
0 |
0.04 |
| Steroids |
0 |
0.04 |